Osborne Partners Capital Management, LLC Amgen Inc Transaction History

Osborne Partners Capital Management, LLC

$1.62 Billion
Q1 2024

A detailed history of Osborne Partners Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Osborne Partners Capital Management, LLC holds 12,365 shares of AMGN stock, worth $3.84 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

12,365

Previous 12,365 -0.0%

Holding current value

$3.84 Million

Previous $3.56 Million 1.29%

% of portfolio

0.22%

Previous 0.23%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $43,730 - $54,291	-200 Reduced 1.59%	12,365 $3.32 Million
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $48,449 - $53,915	-210 Reduced 1.64%	12,565 $3.06 Million
Q1 2021 Apr 27, 2021	BUY	$221.91 - $258.6 $77,668 - $90,510	350 Added 2.82%	12,775 $3.18 Million
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $2.69 Million - $3.2 Million	12,425 New	12,425 $2.86 Million
Q4 2019 Jan 27, 2020	SELL	$189.21 - $243.2 $780,491 - $1 Million	-4,125 Closed	0 $0

Q3 2019 Oct 25, 2019	BUY	$174.11 - $208.62 $21,763 - $26,077	125 Added 3.13%	4,125 $798,000
Q2 2019 Jul 18, 2019	SELL	$166.7 - $195.41 $33,340 - $39,082	-200 Reduced 4.76%	4,000 $737,000
Q1 2019 Apr 24, 2019	SELL	$180.87 - $203.88 $2.29 Million - $2.58 Million	-12,679 Reduced 75.12%	4,200 $798,000
Q3 2018 Oct 26, 2018	SELL	$185.29 - $208.89 $19,640 - $22,142	-106 Reduced 0.62%	16,879 $3.5 Million
Q2 2018 Jul 19, 2018	BUY	$166.05 - $186.51 $9,298 - $10,444	56 Added 0.33%	16,985 $3.14 Million
Q1 2018 Apr 19, 2018	SELL	$169.43 - $198.0 $15,926 - $18,612	-94 Reduced 0.55%	16,929 $2.89 Million
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $2.85 Million - $3.25 Million	17,023	17,023 $3.17 Million

Others Institutions Holding AMGN

# of Institutions

2,932

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Osborne Partners Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Osborne Partners Capital Management, LLC with notifications on news.

Account

Osborne Partners Capital Management, LLC Amgen Inc Transaction History